NCT01383330

A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition

Phase 1 Study of Daewon-ES(A) & Daewon-ES(B) in Healthy Male Volunteers Under Fed Condition

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: Asan Medical Center · Academic / Other
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in healthy male volunteers under fed condition.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	megace	800mg
DRUG	DW-ES(A)	625mg
DRUG	DW-ES(B)	625mg

Timeline

• Start date: 2011-07-01
• Primary completion: 2011-09-01
• First posted: 2011-06-28
• Last updated: 2011-06-28